US Map / California
State CA

Clinical Trials in California

California is home to a significant concentration of clinical research activity, with academic medical centers, community hospitals, and specialized research clinics serving as active trial sites across a broad range of medical conditions. The studies listed here have at least one enrolled site in California and represent Phase 1 through Phase 4 research sponsored by NIH, pharmaceutical companies, device manufacturers, and independent investigators.

Right now ClinicalMetric tracks 839 actively recruiting studies with California sites out of 839 registered in total. The busiest research areas in California are Prostate Cancer, Colorectal Cancer, Schizophrenia. Leading sponsors running trials in the state include Stanford University, University of California, San Francisco, University of California, San Diego. By stage, California trials break down as Phase 1 (181), Phase 2 (253), Phase 3 (145), Phase 4 (26).

All trial data is sourced directly from ClinicalTrials.gov and updated daily. Recruiting status, eligibility criteria, enrollment targets, and contact information are included for each study. Patients and caregivers should review the full eligibility criteria on each trial listing — or consult their treating physician — before contacting a study site.

Total Trials
839
Recruiting Now
839
← Back to US Map
Top Conditions in California
Prostate Cancer (16)Colorectal Cancer (11)Schizophrenia (10)Obesity (10)Healthy (10)Solid Tumor (9)Ovarian Cancer (9)Cancer (8)Advanced Solid Tumors (8)Breast Cancer (8)Multiple Myeloma (7)Alzheimer Disease (7)

Frequently Asked Questions — Clinical Trials in California

How many clinical trials are currently recruiting in California?
ClinicalMetric currently tracks 839 actively recruiting clinical trials with at least one location in California. The total number of registered studies—including active but not currently enrolling trials—is 839. Trial availability is updated daily from ClinicalTrials.gov, and new studies open enrollment regularly throughout the year.
What types of clinical trials are available in California?
California hosts clinical trials across a broad range of medical conditions, including Prostate Cancer, Colorectal Cancer, Schizophrenia, and many others. Trials range from Phase 1 early-safety studies to Phase 4 post-approval surveillance, as well as observational and behavioral research. Academic medical centers, community hospitals, and specialized research clinics throughout California serve as trial sites for studies sponsored by NIH, pharmaceutical companies, and independent investigators.
How do I join a clinical trial near me in California?
To join a clinical trial in California, browse the recruiting studies listed on this page, review the eligibility criteria for each trial, and contact the study site directly. Your primary care physician or specialist can also refer you to clinical trials relevant to your diagnosis. Many academic medical centers in California maintain dedicated clinical trials offices that can match you with appropriate studies based on your medical profile and diagnosis.

Recruiting Trials in California

NCT06502353 N/A
Recruiting
Plexaa For Preconditioning: Gender Affirming Mastectomy
Condition
Nipple Necrosis
Enrollment
15 pts
Location
United States
Sponsor
Plexaa Ltd
View Trial →
NCT07186101 Phase 2
Recruiting
LY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately ...
Condition
Ulcerative Colitis
Enrollment
252 pts
Location
United States, Austria, Brazil
Sponsor
Eli Lilly and Company
View Trial →
NCT07204275 Phase 2, Phase 3
Recruiting
Evaluation of Efficacy, Safety, and Tolerability of Povetacicept in Participants...
Condition
Primary Membranous Nephropathy
Enrollment
176 pts
Location
United States, Australia, Brazil
Sponsor
Vertex Pharmaceuticals Incorpo
View Trial →
NCT00477100 N/A
Recruiting
Biospecimen and Medical Data Collection and Tumor Biopsy in Creating Research Ti...
Condition
Inflammatory Breast Carcinoma
Enrollment
1,200 pts
Location
United States
Sponsor
M.D. Anderson Cancer Center
View Trial →
NCT07007312 Phase 3
Recruiting
Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With...
Condition
Acute Myeloid Leukemia (AML)
Enrollment
1,300 pts
Location
United States, Australia, Belgium
Sponsor
Kura Oncology, Inc.
View Trial →
NCT05682677 N/A
Recruiting
Combined Neuromodulation and Cognitive Training for Post-mTBI Depression
Condition
Depression
Enrollment
72 pts
Location
United States
Sponsor
University of California, San
View Trial →
NCT07085767 Phase 3
Recruiting
Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/...
Condition
Breast Cancer
Enrollment
1,000 pts
Location
United States, Australia, Austria
Sponsor
Olema Pharmaceuticals, Inc.
View Trial →
NCT07232602 Phase 1, Phase 2
Recruiting
KEYMAKER-U04 Substudy 04D: A Clinical Study of New Treatments Given With Enfortu...
Condition
Bladder Cancer
Enrollment
55 pts
Location
United States, Chile, France
Sponsor
Merck Sharp & Dohme LLC
View Trial →
NCT07462377 Phase 1
Recruiting
A Phase 1 Study of EPI-326 in EGFR-mutant NSCLC and HNSCC
Condition
Epidermal Growth Factor
Enrollment
110 pts
Location
United States, South Korea, Taiwan
Sponsor
EpiBiologics
View Trial →
NCT07418775 N/A
Recruiting
Tumor Genomics, Individual Risk Factors, and External Drivers of Health on Healt...
Condition
Meningioma of Brain
Enrollment
3,000 pts
Location
United States
Sponsor
University of California, San
View Trial →
NCT05837845 Phase 2
Recruiting
MDMA-assisted Cognitive Processing Therapy Versus Cognitive Processing Therapy f...
Condition
PTSD
Enrollment
30 pts
Location
United States
Sponsor
Patricia Suppes
View Trial →
NCT04503395 N/A
Recruiting
ShOrt neCK AAA RAndomized Trial - ESAR and FEVAR: SOCRATES
Condition
Aortic Aneurysm, Abdominal
Enrollment
204 pts
Location
United States, Austria, Belgium
Sponsor
FCRE (Foundation for Cardiovas
View Trial →
NCT06634875 Phase 2
Recruiting
Isunakinra Alone and in Combination With Pembrolizumab in Patients With Colorect...
Condition
Colorectal Cancer Metastatic
Enrollment
20 pts
Location
United States
Sponsor
Buzzard Pharmaceuticals
View Trial →
NCT05488457 Phase 2
Recruiting
Oxytocin Pharmacokinetics and Pharmacodynamics
Condition
Post Partum Hemorrhage
Enrollment
100 pts
Location
United States
Sponsor
Stanford University
View Trial →
NCT07511205 Phase 1
Recruiting
A Study to Investigate Safety, Tolerability, Pharmacokinetics and Pharmacodynami...
Condition
Healthy Participants
Enrollment
104 pts
Location
United States, United Kingdom
Sponsor
AstraZeneca
View Trial →
NCT07554521 Phase 2
Recruiting
A Study to Evaluate Efficacy and Safety of Tislelizumab Plus Chemotherapy for Lo...
Condition
Advanced Unresectable Gastric Adenocarcinoma
Enrollment
30 pts
Location
United States
Sponsor
BeOne Medicines
View Trial →
NCT06503614 Phase 2
Recruiting
A Trial of Durvalumab (MEDI4736) Plus Monalizumab in Non-Muscle-Invasive Bladder...
Condition
Non-muscle Invasive Bladder Cancer
Enrollment
60 pts
Location
United States
Sponsor
John Sfakianos
View Trial →
NCT02889016 N/A
Recruiting
Neurobiologic, Immunologic, and Rheumatologic Markers in Youth With PANS
Condition
Pediatric Acute-Onset Neuropsychiatric Syndrome
Enrollment
500 pts
Location
United States
Sponsor
Stanford University
View Trial →
NCT06005038 Phase 1
Recruiting
CogT pSOPT Intervention Study
Condition
Mild Cognitive Impairment
Enrollment
50 pts
Location
United States
Sponsor
Stanford University
View Trial →
NCT04638647 Phase 4
Recruiting
Secukinumab Open Label Roll-over Extension Protocol
Condition
Autoimmunity, Inflammation
Enrollment
1,000 pts
Location
United States, Belgium, Brazil
Sponsor
Novartis Pharmaceuticals
View Trial →
NCT06438315 N/A
Recruiting
SuperSaturated Oxygen Comprehensive Observational Registry
Condition
STEMI - ST Elevation Myocardial Infarction
Enrollment
1,000 pts
Location
United States
Sponsor
TherOx
View Trial →
NCT07147517 N/A
Recruiting
Preparedness Through Respiratory Virus Epidemiology and Community Engagement
Condition
Respiratory Infection Virus
Enrollment
25,000 pts
Location
United States
Sponsor
University of California, San
View Trial →
NCT03618550 Phase 2
Recruiting
Phase II Study of Second- Line Pembrolizumab Plus GVD for Relapsed or Refractory...
Condition
Hodgkin Lymphoma
Enrollment
257 pts
Location
United States
Sponsor
Memorial Sloan Kettering Cance
View Trial →
NCT06342440 N/A
Recruiting
Early Detection of Advanced Adenomas and Colorectal Cancer
Condition
Colorectal Cancer
Enrollment
2,000 pts
Location
United States, China, Italy
Sponsor
City of Hope Medical Center
View Trial →
NCT05757310 Phase 1
Recruiting
A Reduced-Intensity Conditioning Regimen (Cyclophosphamide, Pentostatin, Anti-th...
Condition
Recurrent Severe Aplastic Anemia
Enrollment
6 pts
Location
United States
Sponsor
City of Hope Medical Center
View Trial →
Page 5 of 34 — 839 trials total
← Prev Next →
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology